Skip to content

Discontinued — last reported Q1 '26

EBIT at other companies

ITG
Integer HoldingsITGR
$31.87M-35.7%
Avanos Medical logo
Avanos MedicalAVNS
$8.9M-13.6%
Abbott logo
AbbottABT
Johnson & Johnson logo
Johnson & JohnsonJNJ
Boston Scientific logo
Boston ScientificBSX
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$141.2M+14.3%
Gross profit$109.3M+18.0%
Operating income$526.0K+109%
Net income$108.0K+102%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$146.2M+46.3%
Total debt$76.2M-3.1%
Total equity$491.7M+8.2%
Total assets$644.0M+8.8%

Cash flow

See full
Operating cash flow-$4.0M+63.8%
CapEx$3.9M+76.6%
Free cash flow-$7.8M+40.6%

Valuation

See full
Market cap$1.43B-7.9%
Enterprise value$1.36B-11.2%
P/S2.6×-0.6×

Profitability

See full
Gross margin75.6%+0.8pp
Operating margin-5.1%-1.3pp
Net margin-5.6%-1.5pp
FCF margin9.7%

Returns & leverage

See full
Return on equity-6.1%-1.3pp
Debt / equity0.2×0.0×
Current ratio4.3×+0.2×

Where this comes from

Calculated from AtriCure’s reported figures.

The official record: AtriCure’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about AtriCure's ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AtriCure's EBIT?
AtriCure (ATRC) reported EBIT of $526K in Q1 2026.
How has AtriCure's EBIT changed year-over-year?
AtriCure's EBIT increased by 108.8% year-over-year, from -$5.95M to $526K.
What is the long-term trend for AtriCure's EBIT?
Over 2 years (2022 to 2024), AtriCure's EBIT has grown at a -3.2% compound annual growth rate (CAGR), from -$42.67M to -$40.01M.
What does EBIT mean?
Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.